Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
New Order Win

Panacea Biotec Bags ₹120.9 Cr Order

Panacea Biotec joined the €11.1 million (₹120.90 Crore) EU-funded DENSTAR consortium. The 48-month project advances licensure of its DengiAll vaccine in sub-Saharan Africa.

Key figures
Value₹120.9 Cr
Execution period48 months
Source

NSE filing, NSE: PANACEABIO. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Panacea Biotec Ltd: key numbers

Share price
₹325.10
Market cap
₹1,991 Cr
Revenue (annual)
₹639.8 Cr
Net profit (annual)
₹-5.37 Cr
P/E (TTM)
-279.7×Sector 46.1×
Promoter holding
72.48%+0.00% QoQ
FII holding
2.75%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Panacea Biotec Ltd

All →

Other new order win announcements

All →
19:45 IST BSE
New Order WinShelter Pharma Ltd 543963

Shelter Pharma Bags ₹3.47 Cr Order from Taha Drugs & Chemicals Co. Ltd.; First Vet Veterinary Medicines...

Shelter Pharma received export orders worth Rs. 3.47 Crore from three overseas buyers. Execution follows mutually agreed purchase-order schedules, in the normal course of business.

Value
₹3.47 Cr
From
Taha Drugs & Chemicals Co. Ltd.; First Vet Veterinary Medicines Trading L.L.C; Genet International
Execution
As per mutually agreed purchase order schedules
19:16 IST BSE
New Order WinWorkmates Core2Cloud Solution Ltd 544610

Workmates Core2Cloud Solution Bags ₹2.47 Cr Order from A leading retail broking and financial services company

Workmates Core2Cloud Solution has received a work order from a leading retail broking and financial services company for AWS cloud migration. Initial order value is USD 260,000, with ARR expected to ramp up over about 24 months.

Value
₹2.47 Cr
From
A leading retail broking and financial services company
Execution
Approximately 24 months from commencement of the engagement